FDA Needs Health Communications Advisory Cmte. For DTC Policy, Pitts Says
Executive Summary
An advisory committee on healthcare communications should be created to inform FDA's direct-to-consumer advertising policies, former FDA Associate Commissioner For External Relations Peter Pitts suggested at an FDA public hearing on DTC advertising Nov. 1-2
You may also be interested in...
Risk/Benefit “Fair Balance” In DTC Ads Leads To Confusion – Petition
FDA should redefine its policy of requiring "fair balance" of risk and benefit information in prescription drug advertising, the Coalition for Healthcare Communication says in a March 31 citizen petition
Risk/Benefit “Fair Balance” In DTC Ads Leads To Confusion – Petition
FDA should redefine its policy of requiring "fair balance" of risk and benefit information in prescription drug advertising, the Coalition for Healthcare Communication says in a March 31 citizen petition
PDUFA IV: FDA Stresses Burden Of Industry Meetings In User Fee Discussions
FDA is emphasizing the difficulties of industry requested meetings in its early public discussion of the 2007 Prescription Drug User Fee Act reauthorization